ClinConnect ClinConnect Logo
Search / Trial NCT06779916

Autophagy/Apoptosis Balance in Placental Vascular Pathologies

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Jan 15, 2025

Trial Information

Current as of July 01, 2025

Not yet recruiting

Keywords

Trophoblasts Autophagy Apoptosis Placenta Pregnancy

ClinConnect Summary

This clinical trial, titled "Autophagy/Apoptosis Balance in Placental Vascular Pathologies," is studying how certain cellular processes in the placenta may contribute to pregnancy complications like pre-eclampsia and growth issues in the baby. Scientists are particularly interested in understanding how the balance between cell survival and cell death is affected during these complications. By examining these processes, the researchers hope to find new ways to identify and manage risks for mothers and their babies during pregnancy.

To participate in this trial, women must be pregnant and experiencing complications related to the placenta, such as pre-eclampsia or reduced growth of the baby, and must be delivering at Nîmes University Hospital. Participants should be able to provide informed consent and have health insurance. Women with multiple pregnancies or existing health conditions, like high blood pressure before pregnancy, are not eligible. While the trial is not yet recruiting, those who qualify can expect to contribute to important research that could lead to better understanding and prevention of serious pregnancy complications.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Pregnant women developing a placental vascular complication (preeclampsia and/or intrauterine growth retardation), hospitalized and delivering at Nîmes University Hospital.
  • Pregnant woman with free and informed consent.
  • Pregnant woman affiliated with and/or benefiting from a health insurance scheme.
  • Exclusion criteria:
  • Multiple pregnancy.
  • Presence of hypertension and/or proteinuria prior to pregnancy.
  • Participant in an interventional drug study.
  • Persons in a period of exclusion determined by another study.
  • Persons under court protection, guardianship or curatorship.
  • Persons unable to give consent.
  • Persons for whom it is impossible to give informed information.

About Centre Hospitalier Universitaire De Nīmes

The Centre Hospitalier Universitaire de Nîmes (CHU Nîmes) is a leading academic medical center located in Nîmes, France, dedicated to advancing healthcare through innovative clinical research and patient care. As a prominent sponsor of clinical trials, CHU Nîmes collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous studies aimed at improving treatment outcomes and enhancing medical knowledge across various specialties. With a strong commitment to ethical standards and patient safety, CHU Nîmes fosters a research environment that encourages scientific excellence and contributes to the development of new therapies and healthcare solutions.

Locations

Nîmes, , France

Patients applied

0 patients applied

Trial Officials

Marie PORTES, Dr.

Principal Investigator

Nîmes University Hospital

Mathieu FORTIER, Dr.

Principal Investigator

Nîmes University Hospital

Jean-Christophe GRIS, Pr.

Principal Investigator

Nîmes University Hospital

Eve MOUSTY, Dr.

Principal Investigator

Nîmes University Hospital

Vincent LETOUZEY, Dr.

Principal Investigator

Nîmes University Hospital

Stéphanie HUBERLANT, Dr.

Principal Investigator

Nîmes University Hospital

Chloé BOURGUIGNON, Dr.

Principal Investigator

Nîmes University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported